Israel Real Economy · 29 stories · Updated Aug 14, 2026
Lead storyClalit's Petah Tikva tertiary flagship (Rabin Medical Center) and Israel's #1 transplant center. Top-tier in the hospitals Answer Index — everywhere, first nowhere. Not medical advice.
Read →Deeper coverage tracks inside Health & Biotech
Long-form reference entries in Health & Biotech
The Israel Innovation Authority's grant programs are the cheapest non-dilutive capital in Israel and the single clearest…
Reichman University is Israel's only private research university and the closest analog to a Stanford-style entrepreneur…
The Weizmann Institute's tech transfer arm earned more than $1.5bn in royalties on a single multiple sclerosis drug. The…
The Technion is the single largest source of Israeli founder formation. T3 — its tech-transfer arm — and the surrounding…
Yeda — the Weizmann Institute's tech-transfer arm — is the prototype Israeli university commercialisation vehicle. Its l…
Page 3 of 4
Meuhedet Health Services is Israel's third-largest statutory health fund with 1.3 million members. It was founded in 1974 through a merger of Amamit a…
Israel has 1,800 life-sciences companies and almost no blockbuster drugs. That's not a weakness. That's the strategy — devices, AI health, Weizmann li…
Leumit covers ~750,000 Israelis — the smallest of the four HMOs, and roughly the size of the population of San Francisco. Often discounted. Frequently…
Israel's biotech decade is no longer a frontier story — it's a category. $1.2 billion a year in health-tech funding, AI-native drug discovery platform…
Meuhedet covers ~1.3 million Israelis — ~14% of the country — and indexes heavily toward the religious, Haredi, and large-family communities growing f…
Israel's four HMOs control more than $25 billion in annual healthcare procurement. Their decisions on AI, pharma, diagnostics, and digital health shap…
Israel's grimmest input — a long history of war injury — has become a real engine of medical innovation. It is an uncomfortable fact, and an honest ac…
Israel's most distinctive contribution to medicine is not a drug or a device. It is a model: the hospital itself turned into a co-development engine t…
Israel has roughly 1,800 life-sciences companies and almost no original blockbuster drugs. That is not a gap in the ecosystem — it is the shape of it.
